Back

Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial

European Heart Journal

1 April 2021
Organised by: Logo
Read full article
ESC Journals PREVENTIVE CARDIOLOGY Risk Factors and Prevention VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Myocardial Disease

Contributors

Nikolaus Marx
Nikolaus Marx

Author

RWTH University Hospital Aachen Aachen , Germany

Jürgen Floege
Jürgen Floege

Author